{"gene":"EAF2","run_date":"2026-04-28T17:46:03","timeline":{"discoveries":[{"year":2002,"finding":"EAF2 (ELL-Associated Factor 2) was identified as a second ELL-binding protein, highly homologous to EAF1 (58% identity, 74% conservation). Co-immunoprecipitation from multiple cell lines confirmed the ELL–EAF2 interaction. Confocal microscopy showed endogenous EAF2 and ELL co-localize in a nuclear speckled pattern. Unlike EAF1, EAF2 binds to the amino-terminus (not the carboxy-terminus) of ELL. Both proteins contain transcriptional activation domains in a serine/aspartic acid/glutamic acid-rich region. An MLL-EAF2 fusion immortalized hematopoietic progenitors in retroviral bone marrow transduction assays.","method":"Co-immunoprecipitation, confocal microscopy, deletion mapping, retroviral bone marrow transduction","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP across multiple cell lines, confocal co-localization, deletion mutagenesis, and functional retroviral assay; moderate evidence from single lab with multiple orthogonal methods","pmids":["12446457"],"is_preprint":false},{"year":2003,"finding":"During mouse embryogenesis, Eaf2 is preferentially expressed in the central nervous system, sensory and neuroendocrine organs (brain, spinal cord, ganglia, otocyst, retina, pituitary), and sites of active epithelium-mesenchymal interactions. In the developing lens, Eaf2 is absent from proliferating anterior epithelial cells but present in terminally differentiated primary lens fiber cells and non-proliferating equatorial lens fiber cells, suggesting a role in regulating cell cycle exit and lens maturation.","method":"In situ hybridization, developmental expression analysis","journal":"Developmental dynamics","confidence":"Medium","confidence_rationale":"Tier 3 — localization by in situ hybridization without direct functional manipulation; single lab","pmids":["14517999"],"is_preprint":false},{"year":2003,"finding":"U19 (EAF2) overexpression induced apoptosis in 12 surveyed cell lines, requiring new protein synthesis. Expression of U19 in xenograft prostate tumors markedly induced apoptosis and inhibited tumor growth in vivo. U19 is an androgen/testosterone-regulated gene, and its downregulation was observed in prostate cancer cell lines and 19 of 23 clinical prostate tumor specimens, with allelic loss detected in the same specimens.","method":"Overexpression transfection, in vivo xenograft tumor model, loss of heterozygosity analysis","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 — in vivo xenograft with apoptosis readout, multiple cell lines, LOH analysis; strong evidence from multiple orthogonal approaches","pmids":["12907652"],"is_preprint":false},{"year":2005,"finding":"In Xenopus laevis, EAF2 was identified as a transcriptional target of non-canonical (β-catenin-independent) Wnt-4 signaling, specifically expressed in the developing eye. Loss-of-function of EAF2 (morpholino knockdown) caused loss of eyes. EAF2 overexpression rescued the eye-loss phenotype caused by Wnt-4 loss-of-function. In neuralized animal caps, EAF2 regulated expression of the eye-specific transcription factor Rx, consistent with its role as an RNA polymerase II elongation factor.","method":"Morpholino knockdown, mRNA rescue, loss-of-function, in vivo Xenopus embryo assays","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis (loss-of-function + rescue) in vivo, multiple approaches; strong evidence for EAF2 acting downstream of non-canonical Wnt-4 in eye development","pmids":["15775981"],"is_preprint":false},{"year":2006,"finding":"ELL binding is required for nuclear speckle formation of U19/EAF2. Co-transfection and co-immunoprecipitation showed ELL stabilizes EAF2 protein and enhances its transactivation activity. ELL binding is thus essential for EAF2 nuclear localization, protein stability, and function as a transcription factor.","method":"Co-transfection, co-immunoprecipitation, protein stability assay, transactivation assay","journal":"The Prostate","confidence":"Medium","confidence_rationale":"Tier 2 — multiple functional assays (stability, localization, transactivation) in single lab","pmids":["16114057"],"is_preprint":false},{"year":2007,"finding":"The region of U19/EAF2 essential for apoptosis induction and growth suppression was mapped to amino acids 68–113, which is necessary and sufficient for ELL binding. Co-expression of U19/EAF2 and ELL led to significantly increased cell death and growth suppression. Deletion mutants lacking this domain lost both ELL-binding and apoptotic activity, demonstrating that the ELL-binding domain mediates the pro-apoptotic function of EAF2.","method":"Deletion mutagenesis, co-immunoprecipitation, transfection, colony formation assay","journal":"The Prostate","confidence":"High","confidence_rationale":"Tier 1–2 — mutagenesis with functional rescue/loss readout, defining necessary and sufficient domain; moderate evidence from single lab","pmids":["17044034"],"is_preprint":false},{"year":2007,"finding":"Homozygous or heterozygous deletion of U19/Eaf2 in mice resulted in high rates of lung adenocarcinoma, B-cell lymphoma, hepatocellular carcinoma, and prostatic intraepithelial neoplasia. EAF2 deficiency enhanced cell proliferation and increased epithelial cell size in the prostate, and caused cardiac cell hypertrophy, establishing U19/Eaf2 as a tumor suppressor with a role in growth suppression and cell size control across multiple tissues.","method":"Knockout mouse model, histopathological analysis, immunohistochemistry","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 — clean KO model with defined multi-organ phenotypic readouts; strong evidence for tumor suppressor function","pmids":["17873910"],"is_preprint":false},{"year":2009,"finding":"U19/EAF2 co-immunoprecipitates and binds in vitro to the von Hippel-Lindau protein (pVHL). Deletion mutagenesis revealed that the N-terminus of EAF2 and both the α and β domains of pVHL are required for binding. EAF2 stabilizes pVHL, as demonstrated by protein stability and pulse-chase studies. EAF2 knockout mice and MEFs show reduced pVHL levels, and correspondingly elevated HIF1α levels and activity. EAF2-KO mice exhibit increased angiogenesis in a Matrigel plug assay, consistent with EAF2 modulating HIF1α and angiogenesis via pVHL stabilization.","method":"Co-immunoprecipitation, in vitro binding assay, deletion mutagenesis, protein stability assay, pulse-chase, KO mouse model, Matrigel plug angiogenesis assay","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 1–2 — in vitro binding + mutagenesis + protein stability + in vivo functional readout; multiple orthogonal methods in single lab","pmids":["19258512"],"is_preprint":false},{"year":2009,"finding":"U19/EAF2 co-localizes and co-immunoprecipitates with p53 in transfected cells. In a TSP-1 promoter-driven luciferase reporter assay, p53 suppressed TSP-1 promoter activity and EAF2 co-transfection blocked this p53-mediated suppression, without EAF2 alone affecting TSP-1 promoter activity. EAF2 knockout mice display reduced TSP-1 expression and increased CD31-positive blood vessels in prostate and liver, indicating EAF2 regulates thrombospondin-1 expression by blocking p53 repression of the TSP-1 promoter.","method":"Co-immunoprecipitation, luciferase reporter assay, KO mouse immunohistochemistry","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2–3 — Co-IP interaction with p53, reporter assay defining mechanism, in vivo KO confirmation; single lab with multiple methods","pmids":["19826414"],"is_preprint":false},{"year":2010,"finding":"EAF1 and EAF2/U19 suppress Wnt4 expression by directly binding to the Wnt4 promoter, as demonstrated by chromatin immunoprecipitation (ChIP) assays in zebrafish embryos and mammalian cells. EAF1 and EAF2/U19 are in turn transcriptionally upregulated by Wnt4 (Wnt4a), establishing an auto-regulatory negative feedback loop between Wnt4 and EAF family proteins conserved between zebrafish and mammals. Disruption of this feedback loop during early zebrafish embryogenesis causes developmental defects that can be rescued by restoring appropriate Wnt4a levels.","method":"Chromatin immunoprecipitation, zebrafish morpholino/mRNA rescue, reporter assay, mammalian cell transfection","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1–2 — ChIP demonstrating direct promoter binding, in vivo rescue experiments, conservation across species; multiple orthogonal methods","pmids":["20161747"],"is_preprint":false},{"year":2011,"finding":"EAF2(-/-)VHL(+/-) double-mutant mice show increased incidence of proliferative hepatic vascular lesions compared to either single mutant alone, with elevated HIF1α, VEGF, and microvessel density in liver and prostate. This cooperative effect demonstrates that EAF2 and VHL act together in angiogenic regulation, and concurrent loss results in a synergistic pro-angiogenic phenotype.","method":"Double-mutant mouse model, immunohistochemistry, microvessel density quantification","journal":"Angiogenesis","confidence":"Medium","confidence_rationale":"Tier 2 — epistasis via double-KO mouse model with defined angiogenic phenotype; single lab","pmids":["21638067"],"is_preprint":false},{"year":2013,"finding":"In zebrafish and mammalian cells, Eaf1 and Eaf2 inhibit canonical Wnt/β-catenin signaling and modulate mesodermal and neural patterning. By immunoprecipitation, Eaf1 and Eaf2 bind to the Armadillo repeat region and C-terminus of β-catenin, as well as to c-Jun, Tcf, and Axin, forming a novel complex. The N-terminus of Eaf1/Eaf2 binds β-catenin and acts as a dominant negative, while the C-terminus harbors a suppression domain. Both N- and C-termini must be intact for full suppressive activity. The activity is conserved across species.","method":"Morpholino/mRNA injection in zebrafish, co-immunoprecipitation, β-catenin reporter assay, deletion mapping","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 1–2 — Co-IP identifying complex components, domain mapping, in vivo epistasis, reporter assays; multiple orthogonal methods with conservation","pmids":["23364330"],"is_preprint":false},{"year":2013,"finding":"Concomitant loss of EAF2 and one Pten allele (EAF2-/-Pten+/- mice) induced spontaneous prostate cancer in 33% of mice, demonstrating synergistic functional interaction. Prostatic tissues showed elevated phospho-Akt and phospho-p44/42, increased microvessel density, and phospho-Akt remaining high after castration. Laser-capture microdissection confirmed co-downregulation of EAF2 and Pten in >50% of high Gleason-score clinical prostate cancer specimens.","method":"Double-mutant mouse model, western blotting, immunohistochemistry, laser-capture microdissection, RT-PCR","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis in vivo, multiple biochemical readouts, clinical validation; single lab with multiple methods","pmids":["23708662"],"is_preprint":false},{"year":2013,"finding":"Pirin was identified as an EAF2/U19 binding partner by yeast two-hybrid screening. Co-immunoprecipitation confirmed interaction in mammalian cells. Overexpressed Pirin decreased EAF2/U19 protein levels in LNCaP and PC3 cells, and co-expression of Pirin blocked the growth inhibition induced by EAF2/U19 overexpression in colony formation assays, establishing Pirin as a negative regulator of EAF2 protein levels and tumor-suppressive function.","method":"Yeast two-hybrid, co-immunoprecipitation, protein stability assay, colony formation assay","journal":"The Prostate","confidence":"Medium","confidence_rationale":"Tier 2–3 — yeast two-hybrid validated by Co-IP, functional colony formation assay; single lab","pmids":["24272884"],"is_preprint":false},{"year":2013,"finding":"In EAF2(-/-) mice on C57BL/6J and FVB/NJ backgrounds, mPIN lesions were associated with reactive stroma, statistically increased prostate microvessel density, stromal inflammation preceding epithelial neoplasia, and decreased overall response to androgen deprivation after castration. EAF2 expression in human prostate cancer was negatively correlated with microvessel density.","method":"Knockout mouse model on multiple strains, immunohistochemistry, microvessel density analysis, androgen deprivation experiment","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — multiple KO backgrounds, defined stromal phenotype with temporal characterization; single lab","pmids":["24260246"],"is_preprint":false},{"year":2015,"finding":"EAF2 co-immunoprecipitated with FOXA1 in human prostate cancer cells. EAF2 knockdown enhanced endogenous FOXA1 protein levels, while GFP-EAF2 overexpression decreased FOXA1 protein. EAF2 knockdown enhanced AR-target gene expression, cell proliferation, and migration in LNCaP cells, and FOXA1 knockdown blocked these effects, demonstrating that FOXA1 modulates EAF2's regulation of AR transcriptional activity, proliferation, and migration. The functional relationship was initially identified by RNAi screening in C. elegans eaf-1 mutants.","method":"Co-immunoprecipitation, protein stability assay, RNAi screen in C. elegans, RT-PCR, luciferase reporter, BrdU proliferation assay, transwell migration assay","journal":"The Prostate","confidence":"High","confidence_rationale":"Tier 2 — Co-IP interaction, epistasis via double-knockdown, functional assays across species; multiple orthogonal methods","pmids":["25808853"],"is_preprint":false},{"year":2016,"finding":"EAF2 is selectively upregulated in germinal center (GC) B cells among immune cell types. EAF2 promotes apoptosis of GC B cells both in vitro and in vivo. EAF2-deficient mice develop enlarged GCs and elevated antibody production during T-dependent immune responses. After immunization with type II collagen, EAF2-KO mice rapidly develop severe arthritis with high collagen-specific autoantibodies, and spontaneously produce anti-dsDNA, rheumatoid factor, and anti-nuclear antibodies with aging, demonstrating that EAF2-mediated GC B cell apoptosis limits excessive humoral responses and maintains self-tolerance.","method":"Knockout mouse model, flow cytometry, in vitro apoptosis assay, immunization challenge, autoantibody ELISA, arthritis scoring","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — clean KO model with multiple immune phenotypes, in vitro and in vivo apoptosis confirmation, disease model validation; strong evidence from multiple orthogonal methods","pmids":["26935903"],"is_preprint":false}],"current_model":"EAF2 (U19) is an androgen-regulated RNA polymerase II transcription elongation factor that binds ELL (through an N-terminal domain, aa 68–113) to form nuclear speckles with enhanced stability and transactivation; it acts as a multi-organ tumor suppressor by inducing apoptosis (via its ELL-binding domain), directly binding and stabilizing pVHL to suppress HIF1α-driven angiogenesis, blocking p53-mediated repression of thrombospondin-1, interacting with and modulating FOXA1 and p53 to regulate AR target genes, and inhibiting canonical Wnt/β-catenin signaling through direct binding to β-catenin and its transcriptional complex partners; additionally, EAF2 participates in a negative feedback loop with Wnt4 signaling (acting downstream of non-canonical Wnt-4 in eye development and binding the Wnt4 promoter to suppress its expression), promotes apoptosis of germinal center B cells to prevent excessive humoral immunity and autoimmunity, and synergizes with PTEN loss to drive prostate carcinogenesis."},"narrative":{"teleology":[{"year":2002,"claim":"Identifying EAF2 as a second ELL-binding partner established the molecular basis of an ELL-associated elongation cofactor family and revealed that EAF2 co-localizes with ELL in nuclear speckles.","evidence":"Co-IP across multiple cell lines, confocal microscopy, deletion mapping, and retroviral bone marrow transduction showing MLL-EAF2 fusion immortalizes progenitors","pmids":["12446457"],"confidence":"High","gaps":["Endogenous stoichiometry of EAF2–ELL complexes undefined","Whether EAF2 and EAF1 compete or cooperate for ELL binding unresolved"]},{"year":2003,"claim":"Demonstrating that EAF2 overexpression induces apoptosis in diverse cell lines and that EAF2 is downregulated with allelic loss in clinical prostate cancers established it as a candidate tumor suppressor downstream of androgen signaling.","evidence":"Forced expression in 12 cell lines, in vivo xenograft apoptosis assay, LOH analysis in 23 prostate tumor specimens","pmids":["12907652"],"confidence":"High","gaps":["Molecular pathway from EAF2 to apoptosis execution unknown at this stage","Whether androgen regulation of EAF2 is direct or indirect undetermined"]},{"year":2005,"claim":"Placing EAF2 downstream of non-canonical Wnt-4 signaling in Xenopus eye development and showing it regulates the eye-field transcription factor Rx linked transcription elongation factor activity to a specific developmental patterning pathway.","evidence":"Morpholino knockdown causing eye loss, mRNA rescue of Wnt-4 loss-of-function, neuralized animal cap assays in Xenopus","pmids":["15775981"],"confidence":"High","gaps":["Direct transcriptional targets of EAF2 in eye specification besides Rx not identified","Whether the elongation factor activity is specifically required versus a transcription-activation function unclear"]},{"year":2006,"claim":"Showing that ELL binding is required for EAF2 nuclear speckle localization, protein stability, and transactivation revealed a dependency wherein EAF2 function is contingent on ELL complex formation.","evidence":"Co-transfection, co-IP, protein stability assay, and transactivation reporter assays","pmids":["16114057"],"confidence":"Medium","gaps":["Whether other ELL family members (ELL2, ELL3) can substitute is unknown","Mechanism of ELL-mediated stabilization (proteasomal protection versus other) not determined"]},{"year":2007,"claim":"Mapping the pro-apoptotic and growth-suppressive activity to the ELL-binding domain (aa 68–113) unified the transcription elongation and tumor suppressor functions into a single structural determinant, while Eaf2-knockout mice confirmed multi-organ tumor suppressor activity in vivo.","evidence":"Deletion mutagenesis with colony formation and co-IP readouts; Eaf2-KO mice developing lung adenocarcinoma, B-cell lymphoma, hepatocellular carcinoma, and PIN","pmids":["17044034","17873910"],"confidence":"High","gaps":["Whether apoptosis requires elongation factor activity per se or an independent ELL-mediated function unresolved","Downstream apoptotic effectors not identified"]},{"year":2009,"claim":"Discovery that EAF2 directly binds and stabilizes pVHL, thereby suppressing HIF1α levels and angiogenesis, provided a mechanistic link between EAF2 loss and the pro-angiogenic microenvironment observed in tumors; separately, interaction with p53 to block TSP-1 repression revealed an additional anti-angiogenic axis.","evidence":"Co-IP, in vitro binding, pulse-chase stability assays, Matrigel plug angiogenesis assay in KO mice (pVHL); Co-IP with p53, TSP-1 promoter luciferase reporter, KO mouse IHC (p53/TSP-1)","pmids":["19258512","19826414"],"confidence":"High","gaps":["Whether EAF2 binding to pVHL occurs in the same complex as ELL is unknown","Structural basis of EAF2–pVHL and EAF2–p53 interactions not resolved"]},{"year":2010,"claim":"ChIP-based demonstration that EAF2 directly binds the Wnt4 promoter to suppress its transcription, while Wnt4 upregulates EAF2, established a conserved auto-regulatory negative feedback loop.","evidence":"ChIP in zebrafish embryos and mammalian cells, morpholino/mRNA rescue in zebrafish, reporter assays","pmids":["20161747"],"confidence":"High","gaps":["Whether EAF2 occupancy at the Wnt4 promoter requires ELL unresolved","Full set of EAF2 chromatin targets genome-wide not mapped"]},{"year":2013,"claim":"Identification of EAF2 as an inhibitor of canonical Wnt/β-catenin signaling — binding β-catenin's Armadillo repeats, Tcf, c-Jun, and Axin — expanded its role from a non-canonical Wnt effector to a direct antagonist of the canonical Wnt pathway, while genetic epistasis with Pten loss showed synergistic prostate carcinogenesis in vivo.","evidence":"Co-IP and domain mapping of β-catenin/Tcf/c-Jun/Axin complexes, β-catenin reporter assays, zebrafish epistasis; Eaf2−/−Pten+/− double-mutant mice developing spontaneous prostate cancer with elevated phospho-Akt","pmids":["23364330","23708662"],"confidence":"High","gaps":["Whether EAF2 disrupts β-catenin–Tcf complex on chromatin or sequesters it in the nucleoplasm is unclear","Full spectrum of pathways synergizing with EAF2 loss beyond Pten and VHL not explored"]},{"year":2013,"claim":"Identification of Pirin as a binding partner that destabilizes EAF2 protein and blocks its growth-suppressive function revealed a post-translational regulatory mechanism controlling EAF2 abundance.","evidence":"Yeast two-hybrid screen validated by co-IP in mammalian cells, protein stability assays, colony formation assays","pmids":["24272884"],"confidence":"Medium","gaps":["Mechanism by which Pirin destabilizes EAF2 (proteasomal, lysosomal) not determined","Physiological relevance of Pirin–EAF2 interaction in vivo not tested"]},{"year":2015,"claim":"Demonstrating that EAF2 binds and destabilizes FOXA1, with FOXA1 required for the enhanced AR-target gene expression seen upon EAF2 loss, placed EAF2 upstream of the FOXA1–AR transcriptional axis in prostate cells.","evidence":"Co-IP in prostate cancer cells, double-knockdown epistasis, BrdU proliferation and migration assays, cross-species validation via C. elegans RNAi screen","pmids":["25808853"],"confidence":"High","gaps":["Whether EAF2 regulates FOXA1 at the protein stability or transcriptional level precisely is unresolved","Genome-wide AR-target gene changes upon EAF2 loss not profiled"]},{"year":2016,"claim":"Showing that EAF2 promotes apoptosis specifically in germinal center B cells and that its loss leads to excessive antibody production and spontaneous autoimmunity extended EAF2's tumor-suppressive apoptosis function to immune homeostasis.","evidence":"Eaf2-KO mice with enlarged GCs, elevated antibodies, collagen-induced arthritis model, spontaneous autoantibody production with aging, flow cytometry and in vitro apoptosis assays","pmids":["26935903"],"confidence":"High","gaps":["Molecular mechanism by which EAF2 triggers GC B-cell apoptosis not identified","Whether EAF2's ELL-binding domain is required for B-cell apoptosis unknown","Relationship between EAF2-mediated B-cell lymphoma suppression and GC apoptosis not directly tested"]},{"year":null,"claim":"Critical open questions include the direct transcriptional target repertoire of EAF2 genome-wide, the structural basis of its interactions with ELL, pVHL, β-catenin, and p53, and the molecular effectors through which EAF2 activates apoptosis in epithelial and germinal center B cells.","evidence":"No genome-wide ChIP-seq or structural data reported in the literature","pmids":[],"confidence":"Low","gaps":["No genome-wide chromatin occupancy map for EAF2","No crystal or cryo-EM structure of EAF2 or any EAF2 complex","Downstream apoptotic pathway (intrinsic vs extrinsic) not delineated"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,3,4,5,9]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[9]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[7,8,11,15]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,4]},{"term_id":"GO:0005654","term_label":"nucleoplasm","supporting_discovery_ids":[0,4]}],"pathway":[{"term_id":"GO:0005654","term_label":"nucleoplasm","supporting_discovery_ids":[0]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,3,4,5,9]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[3,9,11]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[2,5,6,16]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[16]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[1,3]}],"complexes":["ELL–EAF2 transcription elongation complex"],"partners":["ELL","VHL","TP53","CTNNB1","FOXA1","PIR","TCF7L2","JUN"],"other_free_text":[]},"mechanistic_narrative":"EAF2 (ELL-associated factor 2/U19) is a transcriptional elongation cofactor and multi-organ tumor suppressor that links RNA polymerase II regulation with apoptosis, angiogenesis, and immune homeostasis. EAF2 binds ELL through an N-terminal domain (aa 68–113) that is required for nuclear speckle formation, protein stability, and pro-apoptotic activity; ELL co-expression enhances EAF2 transactivation and growth-suppressive function [PMID:12446457, PMID:17044034, PMID:16114057]. Beyond transcription elongation, EAF2 directly stabilizes pVHL to suppress HIF1α-driven angiogenesis, interacts with p53 to relieve repression of the anti-angiogenic factor thrombospondin-1, and inhibits canonical Wnt/β-catenin signaling by binding β-catenin, Tcf, and c-Jun [PMID:19258512, PMID:19826414, PMID:23364330]. EAF2 knockout mice develop multi-organ tumors including lung adenocarcinoma, B-cell lymphoma, and prostatic intraepithelial neoplasia, and EAF2 deficiency in germinal center B cells causes excessive humoral immunity and autoantibody production, establishing EAF2 as a critical regulator of apoptosis in both epithelial and lymphoid compartments [PMID:17873910, PMID:26935903]."},"prefetch_data":{"uniprot":{"accession":"Q96CJ1","full_name":"ELL-associated factor 2","aliases":["Testosterone-regulated apoptosis inducer and tumor suppressor protein"],"length_aa":260,"mass_kda":28.8,"function":"Acts as a transcriptional transactivator of TCEA1 elongation activity (By similarity). Acts as a transcriptional transactivator of ELL and ELL2 elongation activities. Potent inducer of apoptosis in prostatic and non-prostatic cell lines. Inhibits prostate tumor growth in vivo","subcellular_location":"Nucleus speckle","url":"https://www.uniprot.org/uniprotkb/Q96CJ1/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/EAF2","classification":"Not Classified","n_dependent_lines":7,"n_total_lines":1208,"dependency_fraction":0.005794701986754967},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/EAF2","total_profiled":1310},"omim":[{"mim_id":"608315","title":"ELL-ASSOCIATED FACTOR 1; EAF1","url":"https://www.omim.org/entry/608315"},{"mim_id":"607659","title":"ELL-ASSOCIATED FACTOR 2; EAF2","url":"https://www.omim.org/entry/607659"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"bone marrow","ntpm":67.8},{"tissue":"lymphoid tissue","ntpm":50.0}],"url":"https://www.proteinatlas.org/search/EAF2"},"hgnc":{"alias_symbol":["BM040","TRAITS","U19"],"prev_symbol":[]},"alphafold":{"accession":"Q96CJ1","domains":[{"cath_id":"-","chopping":"16-110","consensus_level":"high","plddt":95.0615,"start":16,"end":110}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96CJ1","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q96CJ1-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q96CJ1-F1-predicted_aligned_error_v6.png","plddt_mean":70.25},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=EAF2","jax_strain_url":"https://www.jax.org/strain/search?query=EAF2"},"sequence":{"accession":"Q96CJ1","fasta_url":"https://rest.uniprot.org/uniprotkb/Q96CJ1.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q96CJ1/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96CJ1"}},"corpus_meta":[{"pmid":"28622505","id":"PMC_28622505","title":"An Expanded View of Complex Traits: From Polygenic to Omnigenic.","date":"2017","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/28622505","citation_count":1888,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11700286","id":"PMC_11700286","title":"The genetic architecture of quantitative traits.","date":"2001","source":"Annual review of genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11700286","citation_count":684,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33122355","id":"PMC_33122355","title":"Physical traits of cancer.","date":"2020","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/33122355","citation_count":600,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12493905","id":"PMC_12493905","title":"Finding genes that underlie complex traits.","date":"2002","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/12493905","citation_count":577,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32888494","id":"PMC_32888494","title":"The Polygenic and Monogenic Basis of Blood Traits and Diseases.","date":"2020","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/32888494","citation_count":535,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24296534","id":"PMC_24296534","title":"Systems genetics approaches to understand complex traits.","date":"2013","source":"Nature reviews. Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24296534","citation_count":454,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24135279","id":"PMC_24135279","title":"Origins of metastatic traits.","date":"2013","source":"Cancer cell","url":"https://pubmed.ncbi.nlm.nih.gov/24135279","citation_count":432,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25580769","id":"PMC_25580769","title":"Flood adaptive traits and processes: an overview.","date":"2015","source":"The New phytologist","url":"https://pubmed.ncbi.nlm.nih.gov/25580769","citation_count":406,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22077970","id":"PMC_22077970","title":"Abundant pleiotropy in human complex diseases and traits.","date":"2011","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22077970","citation_count":395,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21935886","id":"PMC_21935886","title":"Posttranscriptional regulation of cancer traits by HuR.","date":"2010","source":"Wiley interdisciplinary reviews. RNA","url":"https://pubmed.ncbi.nlm.nih.gov/21935886","citation_count":352,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10700173","id":"PMC_10700173","title":"Analysing complex genetic traits with chromosome substitution strains.","date":"2000","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10700173","citation_count":317,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1509520","id":"PMC_1509520","title":"Microsatellites for linkage analysis of genetic traits.","date":"1992","source":"Trends in genetics : TIG","url":"https://pubmed.ncbi.nlm.nih.gov/1509520","citation_count":284,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32694620","id":"PMC_32694620","title":"Unique and common traits in mycorrhizal symbioses.","date":"2020","source":"Nature reviews. Microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/32694620","citation_count":275,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20332804","id":"PMC_20332804","title":"What traits are carried on mobile genetic elements, and why?","date":"2010","source":"Heredity","url":"https://pubmed.ncbi.nlm.nih.gov/20332804","citation_count":236,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16048784","id":"PMC_16048784","title":"Theoretical models of selection and mutation on quantitative traits.","date":"2005","source":"Philosophical transactions of the Royal Society of London. Series B, Biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/16048784","citation_count":230,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30415840","id":"PMC_30415840","title":"Identity Noise and Adipogenic Traits Characterize Dermal Fibroblast Aging.","date":"2018","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/30415840","citation_count":186,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15592805","id":"PMC_15592805","title":"Regulatory polymorphisms underlying complex disease traits.","date":"2004","source":"Journal of molecular medicine (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/15592805","citation_count":167,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26157023","id":"PMC_26157023","title":"Strategies for fine-mapping complex traits.","date":"2015","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26157023","citation_count":156,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30257690","id":"PMC_30257690","title":"Epigenetic prediction of complex traits and death.","date":"2018","source":"Genome biology","url":"https://pubmed.ncbi.nlm.nih.gov/30257690","citation_count":156,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25387784","id":"PMC_25387784","title":"Invited review: overview of new traits and phenotyping strategies in dairy cattle with a focus on functional traits.","date":"2014","source":"Animal : an international journal of animal bioscience","url":"https://pubmed.ncbi.nlm.nih.gov/25387784","citation_count":144,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24667992","id":"PMC_24667992","title":"Brassinosteroid-mediated regulation of agronomic traits in rice.","date":"2014","source":"Plant cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/24667992","citation_count":142,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32300964","id":"PMC_32300964","title":"Regulation of senescence traits by MAPKs.","date":"2020","source":"GeroScience","url":"https://pubmed.ncbi.nlm.nih.gov/32300964","citation_count":119,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25084048","id":"PMC_25084048","title":"Heterogeneity of dopamine neuron activity across traits and states.","date":"2014","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/25084048","citation_count":117,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15305330","id":"PMC_15305330","title":"Detecting epistatic interactions contributing to quantitative traits.","date":"2004","source":"Genetic epidemiology","url":"https://pubmed.ncbi.nlm.nih.gov/15305330","citation_count":116,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25389175","id":"PMC_25389175","title":"Mucins suppress virulence traits of Candida albicans.","date":"2014","source":"mBio","url":"https://pubmed.ncbi.nlm.nih.gov/25389175","citation_count":111,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37561875","id":"PMC_37561875","title":"DNA methylation networks underlying mammalian traits.","date":"2023","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/37561875","citation_count":93,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15775981","id":"PMC_15775981","title":"Noncanonical Wnt-4 signaling and EAF2 are required for eye development in Xenopus laevis.","date":"2005","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/15775981","citation_count":83,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28880275","id":"PMC_28880275","title":"LGR5 promotes cancer stem cell traits and chemoresistance in cervical cancer.","date":"2017","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/28880275","citation_count":80,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17030144","id":"PMC_17030144","title":"Engineering novel traits in plants through RNA interference.","date":"2006","source":"Trends in plant science","url":"https://pubmed.ncbi.nlm.nih.gov/17030144","citation_count":80,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10689810","id":"PMC_10689810","title":"Properties of spontaneous mutations affecting quantitative traits.","date":"1999","source":"Genetical research","url":"https://pubmed.ncbi.nlm.nih.gov/10689810","citation_count":79,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12446457","id":"PMC_12446457","title":"ELL-associated factor 2 (EAF2), a functional homolog of EAF1 with alternative ELL binding properties.","date":"2002","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/12446457","citation_count":72,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16086848","id":"PMC_16086848","title":"Evolution of selenium utilization traits.","date":"2005","source":"Genome biology","url":"https://pubmed.ncbi.nlm.nih.gov/16086848","citation_count":72,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30358816","id":"PMC_30358816","title":"Measuring phylogenetic signal between categorical traits and phylogenies.","date":"2019","source":"Bioinformatics (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/30358816","citation_count":69,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24443922","id":"PMC_24443922","title":"On the fate of sexual traits under asexuality.","date":"2014","source":"Biological reviews of the Cambridge Philosophical Society","url":"https://pubmed.ncbi.nlm.nih.gov/24443922","citation_count":67,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28475861","id":"PMC_28475861","title":"Widespread Allelic Heterogeneity in Complex Traits.","date":"2017","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28475861","citation_count":67,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12907652","id":"PMC_12907652","title":"Suppression of prostate tumor growth by U19, a novel testosterone-regulated apoptosis inducer.","date":"2003","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/12907652","citation_count":67,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34030967","id":"PMC_34030967","title":"Emerging Patterns of Microbial Functional Traits.","date":"2021","source":"Trends in microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/34030967","citation_count":65,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17873910","id":"PMC_17873910","title":"U19/Eaf2 knockout causes lung adenocarcinoma, B-cell lymphoma, hepatocellular carcinoma and prostatic intraepithelial neoplasia.","date":"2007","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/17873910","citation_count":59,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35676261","id":"PMC_35676261","title":"Global relationships in tree functional traits.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/35676261","citation_count":55,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21890495","id":"PMC_21890495","title":"Multi-ethnic studies in complex traits.","date":"2011","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21890495","citation_count":54,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22976472","id":"PMC_22976472","title":"Genetic and epigenetic contribution to complex traits.","date":"2012","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22976472","citation_count":51,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28673252","id":"PMC_28673252","title":"Comparative muscle transcriptome associated with carcass traits of Nellore cattle.","date":"2017","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/28673252","citation_count":51,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23364330","id":"PMC_23364330","title":"Eaf1 and Eaf2 negatively regulate canonical Wnt/β-catenin signaling.","date":"2013","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/23364330","citation_count":50,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38632397","id":"PMC_38632397","title":"Hybrid speciation driven by multilocus introgression of ecological traits.","date":"2024","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/38632397","citation_count":50,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8657112","id":"PMC_8657112","title":"Characterization of the intron-encoded U19 RNA, a new mammalian small nucleolar RNA that is not associated with fibrillarin.","date":"1996","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8657112","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32796036","id":"PMC_32796036","title":"The ubiquitin system affects agronomic plant traits.","date":"2020","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32796036","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28286704","id":"PMC_28286704","title":"Genetics of Lipid and Lipoprotein Disorders and Traits.","date":"2016","source":"Current genetic medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/28286704","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31961865","id":"PMC_31961865","title":"Roles of Candida albicans Mig1 and Mig2 in glucose repression, pathogenicity traits, and SNF1 essentiality.","date":"2020","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31961865","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25444161","id":"PMC_25444161","title":"Genetics of complex traits in psychiatry.","date":"2014","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/25444161","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37066995","id":"PMC_37066995","title":"GmJAZ3 interacts with GmRR18a and GmMYC2a to regulate seed traits in soybean.","date":"2023","source":"Journal of integrative plant biology","url":"https://pubmed.ncbi.nlm.nih.gov/37066995","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35560157","id":"PMC_35560157","title":"Shared genetic loci between depression and cardiometabolic traits.","date":"2022","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/35560157","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27895608","id":"PMC_27895608","title":"Genetic Consideration of Schizotypal Traits: A Review.","date":"2016","source":"Frontiers in psychology","url":"https://pubmed.ncbi.nlm.nih.gov/27895608","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19826414","id":"PMC_19826414","title":"Tumor suppressor U19/EAF2 regulates thrombospondin-1 expression via p53.","date":"2009","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/19826414","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22231114","id":"PMC_22231114","title":"The unexpected traits associated with core promoter elements.","date":"2011","source":"Transcription","url":"https://pubmed.ncbi.nlm.nih.gov/22231114","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34240182","id":"PMC_34240182","title":"Global Genetic Heterogeneity in Adaptive Traits.","date":"2021","source":"Molecular biology and evolution","url":"https://pubmed.ncbi.nlm.nih.gov/34240182","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36928026","id":"PMC_36928026","title":"Hyperactive nanobacteria with host-dependent traits pervade Omnitrophota.","date":"2023","source":"Nature microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/36928026","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36292733","id":"PMC_36292733","title":"Runs of Homozygosity Revealed Reproductive Traits of Hu Sheep.","date":"2022","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/36292733","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26935903","id":"PMC_26935903","title":"EAF2 mediates germinal centre B-cell apoptosis to suppress excessive immune responses and prevent autoimmunity.","date":"2016","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/26935903","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33562333","id":"PMC_33562333","title":"Metabolomics Intervention Towards Better Understanding of Plant Traits.","date":"2021","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/33562333","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14732447","id":"PMC_14732447","title":"Evolution of developmental traits.","date":"2004","source":"Current opinion in plant biology","url":"https://pubmed.ncbi.nlm.nih.gov/14732447","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19258512","id":"PMC_19258512","title":"U19/Eaf2 binds to and stabilizes von hippel-lindau protein.","date":"2009","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/19258512","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7586641","id":"PMC_7586641","title":"Clinical traits and molecular findings in 46,XX males.","date":"1995","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/7586641","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30969020","id":"PMC_30969020","title":"Ultrastructural traits of apoptosis.","date":"2019","source":"Cell biology international","url":"https://pubmed.ncbi.nlm.nih.gov/30969020","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34874068","id":"PMC_34874068","title":"Properties of phenotypic plasticity in discrete threshold traits.","date":"2021","source":"Evolution; international journal of organic evolution","url":"https://pubmed.ncbi.nlm.nih.gov/34874068","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34405553","id":"PMC_34405553","title":"Clan genomics: From OMIM phenotypic traits to genes and biology.","date":"2021","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/34405553","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23708662","id":"PMC_23708662","title":"Concomitant loss of EAF2/U19 and Pten synergistically promotes prostate carcinogenesis in the mouse model.","date":"2013","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/23708662","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25808853","id":"PMC_25808853","title":"FOXA1 modulates EAF2 regulation of AR transcriptional activity, cell proliferation, and migration in prostate cancer cells.","date":"2015","source":"The Prostate","url":"https://pubmed.ncbi.nlm.nih.gov/25808853","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31300195","id":"PMC_31300195","title":"Plant Networks as Traits and Hypotheses: Moving Beyond Description.","date":"2019","source":"Trends in plant science","url":"https://pubmed.ncbi.nlm.nih.gov/31300195","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36629415","id":"PMC_36629415","title":"Plasmid-Encoded Traits Vary across Environments.","date":"2023","source":"mBio","url":"https://pubmed.ncbi.nlm.nih.gov/36629415","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21638067","id":"PMC_21638067","title":"EAF2 loss enhances angiogenic effects of Von Hippel-Lindau heterozygosity on the murine liver and prostate.","date":"2011","source":"Angiogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/21638067","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24385047","id":"PMC_24385047","title":"SLC6A4 polymorphism, population genetics, and psychiatric traits.","date":"2014","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24385047","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"6371078","id":"PMC_6371078","title":"Traits for sire selection related to udder health and management.","date":"1984","source":"Journal of dairy science","url":"https://pubmed.ncbi.nlm.nih.gov/6371078","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14517999","id":"PMC_14517999","title":"Expression of murine ELL-associated factor 2 (Eaf2) is developmentally regulated.","date":"2003","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/14517999","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25403527","id":"PMC_25403527","title":"Epistasis for quantitative traits in Drosophila.","date":"2015","source":"Methods in molecular biology (Clifton, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/25403527","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37309422","id":"PMC_37309422","title":"Improving architectural traits of maize inflorescences.","date":"2021","source":"Molecular breeding : new strategies in plant improvement","url":"https://pubmed.ncbi.nlm.nih.gov/37309422","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38106437","id":"PMC_38106437","title":"Regulation of seed traits in soybean.","date":"2023","source":"aBIOTECH","url":"https://pubmed.ncbi.nlm.nih.gov/38106437","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32220486","id":"PMC_32220486","title":"Genetic variants in MYF5 affected growth traits and beef quality traits in Chinese Qinchuan cattle.","date":"2020","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/32220486","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26709166","id":"PMC_26709166","title":"Genetic relationships between detailed reproductive traits and performance traits in Holstein-Friesian dairy cattle.","date":"2015","source":"Journal of dairy science","url":"https://pubmed.ncbi.nlm.nih.gov/26709166","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33166245","id":"PMC_33166245","title":"Plasmids encode niche-specific traits in Lactobacillaceae.","date":"2020","source":"Microbial genomics","url":"https://pubmed.ncbi.nlm.nih.gov/33166245","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16114057","id":"PMC_16114057","title":"ELL binding regulates U19/Eaf2 intracellular localization, stability, and transactivation.","date":"2006","source":"The Prostate","url":"https://pubmed.ncbi.nlm.nih.gov/16114057","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20161747","id":"PMC_20161747","title":"Negative feedback regulation of Wnt4 signaling by EAF1 and EAF2/U19.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/20161747","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23050961","id":"PMC_23050961","title":"Genomics of complex traits.","date":"2012","source":"Annals of the New York Academy of Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/23050961","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16216542","id":"PMC_16216542","title":"Complex quality traits: now time to model.","date":"2005","source":"Trends in plant science","url":"https://pubmed.ncbi.nlm.nih.gov/16216542","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26615748","id":"PMC_26615748","title":"Thermophilic growth and enzymatic thermostability are polyphyletic traits within Chaetomiaceae.","date":"2015","source":"Fungal biology","url":"https://pubmed.ncbi.nlm.nih.gov/26615748","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29058037","id":"PMC_29058037","title":"Epigenetic regulation of agronomical traits in Brassicaceae.","date":"2017","source":"Plant cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/29058037","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18507792","id":"PMC_18507792","title":"Towards molecular breeding of reproductive traits in cereal crops.","date":"2008","source":"Plant biotechnology journal","url":"https://pubmed.ncbi.nlm.nih.gov/18507792","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36611708","id":"PMC_36611708","title":"Estimation of Genetic Parameters for Conformation Traits and Milk Production Traits in Chinese Holsteins.","date":"2022","source":"Animals : an open access journal from MDPI","url":"https://pubmed.ncbi.nlm.nih.gov/36611708","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37041326","id":"PMC_37041326","title":"Thermophilic Dehalococcoidia with unusual traits shed light on an unexpected past.","date":"2023","source":"The ISME journal","url":"https://pubmed.ncbi.nlm.nih.gov/37041326","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35347380","id":"PMC_35347380","title":"Pregnancy outcomes among women affected with thalassemia traits.","date":"2022","source":"Archives of gynecology and obstetrics","url":"https://pubmed.ncbi.nlm.nih.gov/35347380","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31861203","id":"PMC_31861203","title":"Expression of Behavioural Traits in Goldendoodles and Labradoodles.","date":"2019","source":"Animals : an open access journal from MDPI","url":"https://pubmed.ncbi.nlm.nih.gov/31861203","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21332828","id":"PMC_21332828","title":"Male reproductive traits and their relationship to reproductive traits in their female progeny: a systematic review.","date":"2011","source":"Reproduction in domestic animals = Zuchthygiene","url":"https://pubmed.ncbi.nlm.nih.gov/21332828","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24272884","id":"PMC_24272884","title":"Pirin down-regulates the EAF2/U19 protein and alleviates its growth inhibition in prostate cancer cells.","date":"2013","source":"The Prostate","url":"https://pubmed.ncbi.nlm.nih.gov/24272884","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33049683","id":"PMC_33049683","title":"Nanog promotes stem-like traits of glioblastoma cells.","date":"2021","source":"Frontiers in bioscience (Landmark edition)","url":"https://pubmed.ncbi.nlm.nih.gov/33049683","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37138640","id":"PMC_37138640","title":"Variation in Sphingomonas traits across habitats and phylogenetic clades.","date":"2023","source":"Frontiers in microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/37138640","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17044034","id":"PMC_17044034","title":"Apoptosis induction and growth suppression by U19/Eaf2 is mediated through its ELL-binding domain.","date":"2007","source":"The Prostate","url":"https://pubmed.ncbi.nlm.nih.gov/17044034","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36046583","id":"PMC_36046583","title":"Epigenetics and its role in effecting agronomical traits.","date":"2022","source":"Frontiers in plant science","url":"https://pubmed.ncbi.nlm.nih.gov/36046583","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36292615","id":"PMC_36292615","title":"Meta-Analysis of SNPs Determining Litter Traits in Pigs.","date":"2022","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/36292615","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35214823","id":"PMC_35214823","title":"Exploring Breakthroughs in Three Traits Belonging to Seed Life.","date":"2022","source":"Plants (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/35214823","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24260246","id":"PMC_24260246","title":"Development of a reactive stroma associated with prostatic intraepithelial neoplasia in EAF2 deficient mice.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24260246","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20118668","id":"PMC_20118668","title":"Inheritance of acquired traits in plants: reinstatement of Lamarck.","date":"2010","source":"Plant signaling & behavior","url":"https://pubmed.ncbi.nlm.nih.gov/20118668","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17081983","id":"PMC_17081983","title":"Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.","date":"2006","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/17081983","citation_count":2861,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16964243","id":"PMC_16964243","title":"A probability-based approach for high-throughput protein phosphorylation analysis and site localization.","date":"2006","source":"Nature biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/16964243","citation_count":1336,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26496610","id":"PMC_26496610","title":"A human interactome in three quantitative dimensions organized by stoichiometries and abundances.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26496610","citation_count":1015,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32296183","id":"PMC_32296183","title":"A reference map of the human binary protein interactome.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32296183","citation_count":849,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10888872","id":"PMC_10888872","title":"DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci.","date":"2000","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10888872","citation_count":843,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11076863","id":"PMC_11076863","title":"DNA cloning using in vitro site-specific recombination.","date":"2000","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/11076863","citation_count":815,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14702039","id":"PMC_14702039","title":"Complete sequencing and characterization of 21,243 full-length human cDNAs.","date":"2003","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14702039","citation_count":754,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22939629","id":"PMC_22939629","title":"A census of human soluble protein complexes.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22939629","citation_count":689,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20946988","id":"PMC_20946988","title":"A Myc network accounts for similarities between embryonic stem and cancer cell transcription programs.","date":"2010","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/20946988","citation_count":565,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16387653","id":"PMC_16387653","title":"ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation.","date":"2006","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/16387653","citation_count":550,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14966270","id":"PMC_14966270","title":"Structural and functional conservation of the NuA4 histone acetyltransferase complex from yeast to humans.","date":"2004","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/14966270","citation_count":490,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35271311","id":"PMC_35271311","title":"OpenCell: Endogenous tagging for the cartography of human cellular organization.","date":"2022","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/35271311","citation_count":432,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26344197","id":"PMC_26344197","title":"Panorama of ancient metazoan macromolecular complexes.","date":"2015","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/26344197","citation_count":407,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17643375","id":"PMC_17643375","title":"Systematic analysis of the protein interaction network for the human transcription machinery reveals the identity of the 7SK capping enzyme.","date":"2007","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/17643375","citation_count":367,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34079125","id":"PMC_34079125","title":"A proximity-dependent biotinylation map of a human cell.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/34079125","citation_count":339,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15196461","id":"PMC_15196461","title":"The highly conserved and multifunctional NuA4 HAT complex.","date":"2004","source":"Current opinion in genetics & development","url":"https://pubmed.ncbi.nlm.nih.gov/15196461","citation_count":323,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15345747","id":"PMC_15345747","title":"Phosphoproteomic analysis of the developing mouse brain.","date":"2004","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/15345747","citation_count":291,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26949251","id":"PMC_26949251","title":"The cell proliferation antigen Ki-67 organises heterochromatin.","date":"2016","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/26949251","citation_count":265,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19156129","id":"PMC_19156129","title":"An integrated workflow for charting the human interaction proteome: insights into the PP2A system.","date":"2009","source":"Molecular systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/19156129","citation_count":223,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"27153538","id":"PMC_27153538","title":"The TIP60 Complex Regulates Bivalent Chromatin Recognition by 53BP1 through Direct H4K20me Binding and H2AK15 Acetylation.","date":"2016","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/27153538","citation_count":217,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16634648","id":"PMC_16634648","title":"Purification of a human SRCAP complex that remodels chromatin by incorporating the histone variant H2A.Z into nucleosomes.","date":"2006","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16634648","citation_count":212,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29568061","id":"PMC_29568061","title":"An AP-MS- and BioID-compatible MAC-tag enables comprehensive mapping of protein interactions and subcellular localizations.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29568061","citation_count":201,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12963728","id":"PMC_12963728","title":"Identification of new subunits of the multiprotein mammalian TRRAP/TIP60-containing histone acetyltransferase complex.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12963728","citation_count":193,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15647280","id":"PMC_15647280","title":"The mammalian YL1 protein is a shared subunit of the TRRAP/TIP60 histone acetyltransferase and SRCAP complexes.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15647280","citation_count":184,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":40639,"output_tokens":4050,"usd":0.091333},"stage2":{"model":"claude-opus-4-6","input_tokens":7514,"output_tokens":3511,"usd":0.188018},"total_usd":0.589147,"stage1_batch_id":"msgbatch_0118RScg3WGaGkaZRtWZbtce","stage2_batch_id":"msgbatch_01Cpfzvtbj42aqp5oYZ5Te2s","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":51716,"output_tokens":5510,"usd":0.118899},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":8673,"output_tokens":3356,"usd":0.190897}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2002,\n      \"finding\": \"EAF2 (ELL-associated factor 2) physically interacts with ELL via the amino-terminus of ELL; both EAF2 and EAF1 contain transcriptional activation domains in a serine/aspartic acid/glutamic acid-rich region; endogenous EAF2 and ELL co-immunoprecipitate and co-localize in a nuclear speckled pattern; the MLL-ELL fusion disrupts the ELL amino-terminal interaction domain, preventing EAF2 binding while retaining EAF1 binding.\",\n      \"method\": \"Co-immunoprecipitation, confocal microscopy, retroviral bone marrow transduction, deletion mutagenesis\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP with endogenous proteins, co-localization, mutagenesis mapping of interaction domain, functional immortalization assay\",\n      \"pmids\": [\"12446457\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"U19 (EAF2) overexpression induces apoptosis in prostate cancer cell lines and suppresses xenograft prostate tumor growth in vivo; new protein synthesis is required for apoptosis induction; U19 is downregulated in prostate cancer cell lines and human prostate tumor specimens with frequent allelic loss.\",\n      \"method\": \"Overexpression in cell lines, xenograft tumor model, LOH analysis, protein synthesis inhibition assay\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo xenograft with defined apoptotic phenotype, multiple cell lines, LOH analysis corroborating loss-of-function\",\n      \"pmids\": [\"12907652\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"EAF2 is a downstream target of noncanonical Wnt-4 signaling in Xenopus laevis eye development; loss of EAF2 function causes loss of eyes; EAF2 functions as an RNA polymerase II elongation factor regulating expression of the eye-specific transcription factor Rx; EAF2 can rescue loss-of-Wnt-4 phenotype.\",\n      \"method\": \"Morpholino loss-of-function, mRNA rescue, neuralized animal cap assay, in situ hybridization\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis (rescue experiments), loss-of-function with specific developmental phenotype, functional elongation factor assay\",\n      \"pmids\": [\"15775981\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"ELL binding is required for nuclear speckle formation of EAF2; ELL binding stabilizes EAF2 protein; ELL binding enhances EAF2 transactivation activity; EAF2 requires ELL interaction for proper nuclear localization and transcriptional function.\",\n      \"method\": \"Co-transfection, co-immunoprecipitation, protein stability assay, transactivation reporter assay\",\n      \"journal\": \"The Prostate\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple functional assays in single lab showing ELL-dependent localization, stability, and transactivation\",\n      \"pmids\": [\"16114057\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"U19/Eaf2 knockout mice develop lung adenocarcinoma, B-cell lymphoma, hepatocellular carcinoma, and prostatic intraepithelial neoplasia; EAF2 deficiency enhances cell proliferation and increases epithelial cell size in the prostate; cardiac cell hypertrophy is also observed, indicating roles in growth suppression and cell size control.\",\n      \"method\": \"Knockout mouse model, histopathology, cell proliferation assays\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean knockout mouse with multiple defined tissue phenotypes, replicated across organs\",\n      \"pmids\": [\"17873910\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"The ELL-binding domain of EAF2 (amino acids 68–113) is necessary and sufficient for apoptosis induction and growth suppression; co-expression of EAF2 and ELL synergistically increases cell death; ELL interaction is essential for EAF2-mediated apoptosis.\",\n      \"method\": \"Deletion mutagenesis, transfection, colony formation assay, co-immunoprecipitation\",\n      \"journal\": \"The Prostate\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — domain mapping by mutagenesis with functional apoptosis/growth suppression readout and co-IP validation\",\n      \"pmids\": [\"17044034\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"U19/EAF2 co-localizes and co-immunoprecipitates with p53; EAF2 blocks p53-mediated repression of the thrombospondin-1 (TSP-1) promoter, thereby regulating TSP-1 expression; U19/EAF2 knockout mice show reduced TSP-1 and increased angiogenesis (increased CD31-positive blood vessels in the liver).\",\n      \"method\": \"Co-immunoprecipitation, luciferase reporter assay, immunohistochemistry (CD31), knockout mouse analysis\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP plus reporter assay plus in vivo knockout validation, single lab\",\n      \"pmids\": [\"19826414\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"EAF2 physically binds to VHL (von Hippel-Lindau protein) via its NH2-terminus interacting with both alpha and beta domains of pVHL; EAF2 stabilizes pVHL protein; loss of EAF2 in knockout mice reduces pVHL levels in testes and MEFs; EAF2 knockout MEFs show elevated HIF1α levels and activity; EAF2 knockout mice exhibit increased angiogenesis in Matrigel plug assays, aspermatogenesis, and vascular abnormalities.\",\n      \"method\": \"Co-immunoprecipitation, in vitro binding assay, deletion mutagenesis, protein stability/pulse-chase assay, knockout mouse analysis, Matrigel plug assay\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro binding with mutagenesis, protein stability pulse-chase, in vivo knockout validation with multiple readouts\",\n      \"pmids\": [\"19258512\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"EAF1 and EAF2/U19 are upregulated by Wnt4 signaling; EAF1 and EAF2 suppress Wnt4 expression by directly binding to the Wnt4 promoter; an auto-regulatory negative feedback loop exists between Wnt4 and EAF proteins, conserved between zebrafish and mammals; maintaining appropriate Wnt4a levels through this feedback loop is required for normal early embryonic development.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP), zebrafish embryo rescue experiments, mammalian cell reporter assays, morpholino knockdown\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — ChIP demonstrating direct promoter binding, in vivo rescue epistasis, cross-species conservation\",\n      \"pmids\": [\"20161747\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"EAF2 loss cooperates with VHL heterozygosity to increase angiogenesis in liver and prostate; EAF2-/-VHL+/- mice show increased hepatic vascular lesions, microvessel density, and elevated HIF1α and VEGF staining compared to either single mutant, demonstrating synergistic cooperation between EAF2 and VHL in angiogenic regulation.\",\n      \"method\": \"Mouse genetic crosses, immunohistochemistry for microvessel density/HIF1α/VEGF, histopathology\",\n      \"journal\": \"Angiogenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis in vivo with quantitative phenotypic readouts, single lab\",\n      \"pmids\": [\"21638067\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Eaf1 and Eaf2 inhibit canonical Wnt/β-catenin signaling in zebrafish and cultured cells; Eaf2 binds to the Armadillo repeat region and C-terminus of β-catenin and forms a complex with c-Jun, Tcf, and Axin; the N-terminus of Eaf2 mediates β-catenin binding and shows dominant-negative activity; both N- and C-termini must be intact for full Eaf2 suppressive activity.\",\n      \"method\": \"Morpholino loss-of-function, mRNA gain-of-function in zebrafish, β-catenin reporter assays, co-immunoprecipitation\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — Co-IP of complex components, domain mutagenesis, in vivo epistasis, reporter assays across two systems\",\n      \"pmids\": [\"23364330\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Concomitant loss of EAF2 and one Pten allele synergistically induces prostate cancer in mice; EAF2-/-Pten+/- prostates show elevated phospho-Akt, phospho-p44/42 MAPK, and microvessel density; phospho-Akt remains elevated after castration; synergistic increase in prostate epithelial proliferation occurs in both intact and castrated double-mutant mice.\",\n      \"method\": \"Compound knockout mouse model, immunohistochemistry, laser-capture microdissection with RT-PCR, histopathology\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with defined pathway markers (pAkt, pMAPK), in vivo tumor model, castration experiment\",\n      \"pmids\": [\"23708662\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Pirin co-immunoprecipitates with EAF2/U19 and decreases EAF2/U19 protein levels in prostate cancer cell lines; Pirin overexpression blocks EAF2/U19-induced growth inhibition in LNCaP colony formation assays; identified via yeast two-hybrid screening.\",\n      \"method\": \"Yeast two-hybrid screen, co-immunoprecipitation, colony formation assay\",\n      \"journal\": \"The Prostate\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — yeast two-hybrid plus Co-IP plus functional colony assay, single lab\",\n      \"pmids\": [\"24272884\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"EAF2 knockout mice on C57BL/6J and FVB/NJ backgrounds develop prostatic intraepithelial neoplasia with reactive stroma, increased prostate microvessel density, and stromal inflammation preceding epithelial neoplasia; EAF2-deficient mice have decreased overall response to androgen deprivation; EAF2 expression in human prostate cancer is negatively correlated with microvessel density.\",\n      \"method\": \"Knockout mouse model on multiple genetic backgrounds, immunohistochemistry, androgen deprivation experiment\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined histological phenotypes across multiple strains, temporal ordering of stromal vs. epithelial changes\",\n      \"pmids\": [\"24260246\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"EAF2 co-immunoprecipitates with FOXA1; EAF2 knockdown enhances endogenous FOXA1 protein levels whereas EAF2 overexpression down-regulates FOXA1; EAF2 knockdown increases AR-target gene expression, cell proliferation, and migration in LNCaP cells; FOXA1 knockdown inhibits the effects of EAF2 knockdown on AR signaling, proliferation, and migration, demonstrating that FOXA1 modulates EAF2 regulation of AR transcriptional activity.\",\n      \"method\": \"Co-immunoprecipitation, protein stability assay, siRNA knockdown, luciferase reporter assay, BrdU proliferation assay, transwell migration assay, C. elegans RNAi screen\",\n      \"journal\": \"The Prostate\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP plus multiple functional assays (reporter, proliferation, migration) with epistasis established by double knockdown, cross-species screen\",\n      \"pmids\": [\"25808853\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"EAF2 is selectively upregulated in germinal centre (GC) B cells and promotes apoptosis of GC B cells in vitro and in vivo; EAF2 deficiency results in enlarged GCs and elevated antibody production; EAF2-deficient mice develop autoimmune arthritis after collagen immunization with high collagen-specific autoantibodies, and spontaneously produce anti-dsDNA, rheumatoid factor, and anti-nuclear antibodies, demonstrating that EAF2-mediated apoptosis in GC B cells limits excessive humoral immune responses and maintains self-tolerance.\",\n      \"method\": \"Knockout mouse model, flow cytometry, in vitro apoptosis assay, immunization experiments, autoantibody measurement\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with multiple immune phenotypes, in vitro and in vivo apoptosis assays, mechanistic link to GC biology\",\n      \"pmids\": [\"26935903\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"EAF2 (U19) is an androgen-responsive transcription elongation factor that physically associates with ELL (stabilizing EAF2 and enabling nuclear speckle localization and transactivation), binds and stabilizes VHL to suppress HIF1α-driven angiogenesis, interacts with p53 to relieve TSP-1 repression, inhibits canonical Wnt/β-catenin signaling by forming a complex with β-catenin/Tcf/Axin, and participates in a negative feedback loop with Wnt4; its ELL-binding domain is required for apoptosis induction and tumor suppression, and loss of EAF2 in vivo causes multi-organ tumorigenesis, prostatic intraepithelial neoplasia with reactive stroma, dysregulated germinal centre B-cell apoptosis leading to autoimmunity, and synergistic prostate carcinogenesis when combined with Pten loss.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nI'll systematically classify papers and extract discoveries only from KEEP papers.\n\n**Classification of relevant EAF2 papers (KEEP):**\n- PMID:12446457 — EAF2 identified as ELL-binding protein (KEEP)\n- PMID:15775981 — EAF2 in Xenopus eye development (KEEP, ortholog)\n- PMID:12907652 — U19/EAF2 tumor suppressor (KEEP)\n- PMID:17873910 — U19/Eaf2 knockout mouse (KEEP)\n- PMID:23364330 — Eaf1/Eaf2 and Wnt/β-catenin (KEEP, ortholog zebrafish)\n- PMID:19826414 — EAF2 regulates TSP-1 via p53 (KEEP)\n- PMID:19258512 — EAF2 binds/stabilizes VHL (KEEP)\n- PMID:26935903 — EAF2 in GC B-cell apoptosis (KEEP)\n- PMID:23708662 — EAF2/Pten synergy in prostate cancer (KEEP)\n- PMID:25808853 — FOXA1 modulates EAF2 (KEEP)\n- PMID:21638067 — EAF2 loss enhances angiogenesis with VHL (KEEP)\n- PMID:16114057 — ELL binding regulates EAF2 localization/stability (KEEP)\n- PMID:20161747 — Negative feedback with Wnt4 (KEEP)\n- PMID:17044034 — Apoptosis via ELL-binding domain (KEEP)\n- PMID:24272884 — Pirin downregulates EAF2 (KEEP)\n- PMID:14517999 — Eaf2 developmental expression (KEEP)\n- PMID:24260246 — Reactive stroma in EAF2 KO mice (KEEP)\n- PMID:8657112 — U19 RNA (EXCLUDE — this is the snoRNA U19, not EAF2 protein; alias collision/alt-locus product)\n\nAll other papers in both lists are clearly off-target (genetics of traits, plant biology, dairy cattle, unrelated proteins, etc.) — EXCLUDE.\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2002,\n      \"finding\": \"EAF2 (ELL-Associated Factor 2) was identified as a second ELL-binding protein, highly homologous to EAF1 (58% identity, 74% conservation). Co-immunoprecipitation from multiple cell lines confirmed the ELL–EAF2 interaction. Confocal microscopy showed endogenous EAF2 and ELL co-localize in a nuclear speckled pattern. Unlike EAF1, EAF2 binds to the amino-terminus (not the carboxy-terminus) of ELL. Both proteins contain transcriptional activation domains in a serine/aspartic acid/glutamic acid-rich region. An MLL-EAF2 fusion immortalized hematopoietic progenitors in retroviral bone marrow transduction assays.\",\n      \"method\": \"Co-immunoprecipitation, confocal microscopy, deletion mapping, retroviral bone marrow transduction\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP across multiple cell lines, confocal co-localization, deletion mutagenesis, and functional retroviral assay; moderate evidence from single lab with multiple orthogonal methods\",\n      \"pmids\": [\"12446457\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"During mouse embryogenesis, Eaf2 is preferentially expressed in the central nervous system, sensory and neuroendocrine organs (brain, spinal cord, ganglia, otocyst, retina, pituitary), and sites of active epithelium-mesenchymal interactions. In the developing lens, Eaf2 is absent from proliferating anterior epithelial cells but present in terminally differentiated primary lens fiber cells and non-proliferating equatorial lens fiber cells, suggesting a role in regulating cell cycle exit and lens maturation.\",\n      \"method\": \"In situ hybridization, developmental expression analysis\",\n      \"journal\": \"Developmental dynamics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — localization by in situ hybridization without direct functional manipulation; single lab\",\n      \"pmids\": [\"14517999\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"U19 (EAF2) overexpression induced apoptosis in 12 surveyed cell lines, requiring new protein synthesis. Expression of U19 in xenograft prostate tumors markedly induced apoptosis and inhibited tumor growth in vivo. U19 is an androgen/testosterone-regulated gene, and its downregulation was observed in prostate cancer cell lines and 19 of 23 clinical prostate tumor specimens, with allelic loss detected in the same specimens.\",\n      \"method\": \"Overexpression transfection, in vivo xenograft tumor model, loss of heterozygosity analysis\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo xenograft with apoptosis readout, multiple cell lines, LOH analysis; strong evidence from multiple orthogonal approaches\",\n      \"pmids\": [\"12907652\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"In Xenopus laevis, EAF2 was identified as a transcriptional target of non-canonical (β-catenin-independent) Wnt-4 signaling, specifically expressed in the developing eye. Loss-of-function of EAF2 (morpholino knockdown) caused loss of eyes. EAF2 overexpression rescued the eye-loss phenotype caused by Wnt-4 loss-of-function. In neuralized animal caps, EAF2 regulated expression of the eye-specific transcription factor Rx, consistent with its role as an RNA polymerase II elongation factor.\",\n      \"method\": \"Morpholino knockdown, mRNA rescue, loss-of-function, in vivo Xenopus embryo assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis (loss-of-function + rescue) in vivo, multiple approaches; strong evidence for EAF2 acting downstream of non-canonical Wnt-4 in eye development\",\n      \"pmids\": [\"15775981\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"ELL binding is required for nuclear speckle formation of U19/EAF2. Co-transfection and co-immunoprecipitation showed ELL stabilizes EAF2 protein and enhances its transactivation activity. ELL binding is thus essential for EAF2 nuclear localization, protein stability, and function as a transcription factor.\",\n      \"method\": \"Co-transfection, co-immunoprecipitation, protein stability assay, transactivation assay\",\n      \"journal\": \"The Prostate\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple functional assays (stability, localization, transactivation) in single lab\",\n      \"pmids\": [\"16114057\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"The region of U19/EAF2 essential for apoptosis induction and growth suppression was mapped to amino acids 68–113, which is necessary and sufficient for ELL binding. Co-expression of U19/EAF2 and ELL led to significantly increased cell death and growth suppression. Deletion mutants lacking this domain lost both ELL-binding and apoptotic activity, demonstrating that the ELL-binding domain mediates the pro-apoptotic function of EAF2.\",\n      \"method\": \"Deletion mutagenesis, co-immunoprecipitation, transfection, colony formation assay\",\n      \"journal\": \"The Prostate\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — mutagenesis with functional rescue/loss readout, defining necessary and sufficient domain; moderate evidence from single lab\",\n      \"pmids\": [\"17044034\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Homozygous or heterozygous deletion of U19/Eaf2 in mice resulted in high rates of lung adenocarcinoma, B-cell lymphoma, hepatocellular carcinoma, and prostatic intraepithelial neoplasia. EAF2 deficiency enhanced cell proliferation and increased epithelial cell size in the prostate, and caused cardiac cell hypertrophy, establishing U19/Eaf2 as a tumor suppressor with a role in growth suppression and cell size control across multiple tissues.\",\n      \"method\": \"Knockout mouse model, histopathological analysis, immunohistochemistry\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO model with defined multi-organ phenotypic readouts; strong evidence for tumor suppressor function\",\n      \"pmids\": [\"17873910\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"U19/EAF2 co-immunoprecipitates and binds in vitro to the von Hippel-Lindau protein (pVHL). Deletion mutagenesis revealed that the N-terminus of EAF2 and both the α and β domains of pVHL are required for binding. EAF2 stabilizes pVHL, as demonstrated by protein stability and pulse-chase studies. EAF2 knockout mice and MEFs show reduced pVHL levels, and correspondingly elevated HIF1α levels and activity. EAF2-KO mice exhibit increased angiogenesis in a Matrigel plug assay, consistent with EAF2 modulating HIF1α and angiogenesis via pVHL stabilization.\",\n      \"method\": \"Co-immunoprecipitation, in vitro binding assay, deletion mutagenesis, protein stability assay, pulse-chase, KO mouse model, Matrigel plug angiogenesis assay\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro binding + mutagenesis + protein stability + in vivo functional readout; multiple orthogonal methods in single lab\",\n      \"pmids\": [\"19258512\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"U19/EAF2 co-localizes and co-immunoprecipitates with p53 in transfected cells. In a TSP-1 promoter-driven luciferase reporter assay, p53 suppressed TSP-1 promoter activity and EAF2 co-transfection blocked this p53-mediated suppression, without EAF2 alone affecting TSP-1 promoter activity. EAF2 knockout mice display reduced TSP-1 expression and increased CD31-positive blood vessels in prostate and liver, indicating EAF2 regulates thrombospondin-1 expression by blocking p53 repression of the TSP-1 promoter.\",\n      \"method\": \"Co-immunoprecipitation, luciferase reporter assay, KO mouse immunohistochemistry\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — Co-IP interaction with p53, reporter assay defining mechanism, in vivo KO confirmation; single lab with multiple methods\",\n      \"pmids\": [\"19826414\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"EAF1 and EAF2/U19 suppress Wnt4 expression by directly binding to the Wnt4 promoter, as demonstrated by chromatin immunoprecipitation (ChIP) assays in zebrafish embryos and mammalian cells. EAF1 and EAF2/U19 are in turn transcriptionally upregulated by Wnt4 (Wnt4a), establishing an auto-regulatory negative feedback loop between Wnt4 and EAF family proteins conserved between zebrafish and mammals. Disruption of this feedback loop during early zebrafish embryogenesis causes developmental defects that can be rescued by restoring appropriate Wnt4a levels.\",\n      \"method\": \"Chromatin immunoprecipitation, zebrafish morpholino/mRNA rescue, reporter assay, mammalian cell transfection\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — ChIP demonstrating direct promoter binding, in vivo rescue experiments, conservation across species; multiple orthogonal methods\",\n      \"pmids\": [\"20161747\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"EAF2(-/-)VHL(+/-) double-mutant mice show increased incidence of proliferative hepatic vascular lesions compared to either single mutant alone, with elevated HIF1α, VEGF, and microvessel density in liver and prostate. This cooperative effect demonstrates that EAF2 and VHL act together in angiogenic regulation, and concurrent loss results in a synergistic pro-angiogenic phenotype.\",\n      \"method\": \"Double-mutant mouse model, immunohistochemistry, microvessel density quantification\",\n      \"journal\": \"Angiogenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — epistasis via double-KO mouse model with defined angiogenic phenotype; single lab\",\n      \"pmids\": [\"21638067\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"In zebrafish and mammalian cells, Eaf1 and Eaf2 inhibit canonical Wnt/β-catenin signaling and modulate mesodermal and neural patterning. By immunoprecipitation, Eaf1 and Eaf2 bind to the Armadillo repeat region and C-terminus of β-catenin, as well as to c-Jun, Tcf, and Axin, forming a novel complex. The N-terminus of Eaf1/Eaf2 binds β-catenin and acts as a dominant negative, while the C-terminus harbors a suppression domain. Both N- and C-termini must be intact for full suppressive activity. The activity is conserved across species.\",\n      \"method\": \"Morpholino/mRNA injection in zebrafish, co-immunoprecipitation, β-catenin reporter assay, deletion mapping\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — Co-IP identifying complex components, domain mapping, in vivo epistasis, reporter assays; multiple orthogonal methods with conservation\",\n      \"pmids\": [\"23364330\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Concomitant loss of EAF2 and one Pten allele (EAF2-/-Pten+/- mice) induced spontaneous prostate cancer in 33% of mice, demonstrating synergistic functional interaction. Prostatic tissues showed elevated phospho-Akt and phospho-p44/42, increased microvessel density, and phospho-Akt remaining high after castration. Laser-capture microdissection confirmed co-downregulation of EAF2 and Pten in >50% of high Gleason-score clinical prostate cancer specimens.\",\n      \"method\": \"Double-mutant mouse model, western blotting, immunohistochemistry, laser-capture microdissection, RT-PCR\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis in vivo, multiple biochemical readouts, clinical validation; single lab with multiple methods\",\n      \"pmids\": [\"23708662\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Pirin was identified as an EAF2/U19 binding partner by yeast two-hybrid screening. Co-immunoprecipitation confirmed interaction in mammalian cells. Overexpressed Pirin decreased EAF2/U19 protein levels in LNCaP and PC3 cells, and co-expression of Pirin blocked the growth inhibition induced by EAF2/U19 overexpression in colony formation assays, establishing Pirin as a negative regulator of EAF2 protein levels and tumor-suppressive function.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation, protein stability assay, colony formation assay\",\n      \"journal\": \"The Prostate\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — yeast two-hybrid validated by Co-IP, functional colony formation assay; single lab\",\n      \"pmids\": [\"24272884\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"In EAF2(-/-) mice on C57BL/6J and FVB/NJ backgrounds, mPIN lesions were associated with reactive stroma, statistically increased prostate microvessel density, stromal inflammation preceding epithelial neoplasia, and decreased overall response to androgen deprivation after castration. EAF2 expression in human prostate cancer was negatively correlated with microvessel density.\",\n      \"method\": \"Knockout mouse model on multiple strains, immunohistochemistry, microvessel density analysis, androgen deprivation experiment\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple KO backgrounds, defined stromal phenotype with temporal characterization; single lab\",\n      \"pmids\": [\"24260246\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"EAF2 co-immunoprecipitated with FOXA1 in human prostate cancer cells. EAF2 knockdown enhanced endogenous FOXA1 protein levels, while GFP-EAF2 overexpression decreased FOXA1 protein. EAF2 knockdown enhanced AR-target gene expression, cell proliferation, and migration in LNCaP cells, and FOXA1 knockdown blocked these effects, demonstrating that FOXA1 modulates EAF2's regulation of AR transcriptional activity, proliferation, and migration. The functional relationship was initially identified by RNAi screening in C. elegans eaf-1 mutants.\",\n      \"method\": \"Co-immunoprecipitation, protein stability assay, RNAi screen in C. elegans, RT-PCR, luciferase reporter, BrdU proliferation assay, transwell migration assay\",\n      \"journal\": \"The Prostate\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP interaction, epistasis via double-knockdown, functional assays across species; multiple orthogonal methods\",\n      \"pmids\": [\"25808853\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"EAF2 is selectively upregulated in germinal center (GC) B cells among immune cell types. EAF2 promotes apoptosis of GC B cells both in vitro and in vivo. EAF2-deficient mice develop enlarged GCs and elevated antibody production during T-dependent immune responses. After immunization with type II collagen, EAF2-KO mice rapidly develop severe arthritis with high collagen-specific autoantibodies, and spontaneously produce anti-dsDNA, rheumatoid factor, and anti-nuclear antibodies with aging, demonstrating that EAF2-mediated GC B cell apoptosis limits excessive humoral responses and maintains self-tolerance.\",\n      \"method\": \"Knockout mouse model, flow cytometry, in vitro apoptosis assay, immunization challenge, autoantibody ELISA, arthritis scoring\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO model with multiple immune phenotypes, in vitro and in vivo apoptosis confirmation, disease model validation; strong evidence from multiple orthogonal methods\",\n      \"pmids\": [\"26935903\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"EAF2 (U19) is an androgen-regulated RNA polymerase II transcription elongation factor that binds ELL (through an N-terminal domain, aa 68–113) to form nuclear speckles with enhanced stability and transactivation; it acts as a multi-organ tumor suppressor by inducing apoptosis (via its ELL-binding domain), directly binding and stabilizing pVHL to suppress HIF1α-driven angiogenesis, blocking p53-mediated repression of thrombospondin-1, interacting with and modulating FOXA1 and p53 to regulate AR target genes, and inhibiting canonical Wnt/β-catenin signaling through direct binding to β-catenin and its transcriptional complex partners; additionally, EAF2 participates in a negative feedback loop with Wnt4 signaling (acting downstream of non-canonical Wnt-4 in eye development and binding the Wnt4 promoter to suppress its expression), promotes apoptosis of germinal center B cells to prevent excessive humoral immunity and autoimmunity, and synergizes with PTEN loss to drive prostate carcinogenesis.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"EAF2 is a tumor suppressor and transcription elongation-associated factor that couples RNA polymerase II elongation to growth control, apoptosis, and angiogenic homeostasis across multiple tissues. EAF2 physically associates with ELL through an N-terminal domain (aa 68–113) that is required for nuclear speckle localization, protein stabilization, transactivation, and apoptosis induction; this interaction is disrupted by the MLL-ELL leukemia fusion [PMID:12446457, PMID:16114057, PMID:17044034]. EAF2 restrains angiogenesis by binding and stabilizing VHL, thereby suppressing HIF1α, and independently relieves p53-mediated repression of thrombospondin-1 (TSP-1); it also inhibits canonical Wnt/β-catenin signaling by forming a complex with β-catenin, Tcf, and Axin, and participates in a Wnt4–EAF2 negative feedback loop conserved from zebrafish to mammals [PMID:19258512, PMID:19826414, PMID:23364330, PMID:20161747]. Eaf2 knockout mice develop multi-organ tumorigenesis including prostatic intraepithelial neoplasia, lung adenocarcinoma, hepatocellular carcinoma, and B-cell lymphoma, and EAF2 loss in germinal center B cells causes defective apoptosis leading to spontaneous autoantibody production and autoimmune arthritis [PMID:17873910, PMID:26935903].\",\n  \"teleology\": [\n    {\n      \"year\": 2002,\n      \"claim\": \"Identifying EAF2 as a direct ELL-binding partner established the molecular framework for understanding how EAF2 enters the transcription elongation machinery and showed that the MLL-ELL fusion disrupts this interaction.\",\n      \"evidence\": \"Reciprocal co-immunoprecipitation of endogenous proteins, confocal co-localization in nuclear speckles, deletion mutagenesis mapping the ELL N-terminus as the EAF2 interaction site\",\n      \"pmids\": [\"12446457\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether EAF2 directly contacts Pol II or acts solely through ELL was not resolved\", \"The transcription targets regulated by the ELL–EAF2 complex were not identified\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Demonstrating that EAF2 overexpression induces apoptosis and suppresses xenograft tumor growth, combined with frequent allelic loss in human prostate tumors, established EAF2 as a candidate tumor suppressor.\",\n      \"evidence\": \"Overexpression in prostate cancer cell lines, nude mouse xenograft, LOH analysis of human prostate tumors, cycloheximide block showing requirement for new protein synthesis\",\n      \"pmids\": [\"12907652\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The downstream apoptotic pathway engaged by EAF2 was not identified\", \"Whether EAF2 loss is a driver or passenger event in human prostate cancer remained unclear\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Placing EAF2 downstream of non-canonical Wnt4 signaling in Xenopus eye development revealed a developmental role as an RNA Pol II elongation factor controlling tissue-specific gene expression (Rx).\",\n      \"evidence\": \"Morpholino knockdown causing eye loss, mRNA rescue, epistasis placing EAF2 downstream of Wnt4 and upstream of Rx\",\n      \"pmids\": [\"15775981\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether EAF2 directly elongates the Rx locus or acts indirectly was not resolved\", \"Conservation of this Wnt4–EAF2–Rx axis in mammalian eye development was not tested\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Showing that ELL binding stabilizes EAF2 protein, directs its nuclear speckle localization, and is required for transactivation established ELL as the obligate upstream regulator of EAF2 function.\",\n      \"evidence\": \"Co-transfection protein stability assays, reporter assays, localization studies in transfected cells\",\n      \"pmids\": [\"16114057\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Endogenous validation of ELL-dependent EAF2 stability was not shown\", \"Structural basis of the stabilization mechanism was not determined\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Mapping the ELL-binding domain (aa 68–113) as necessary and sufficient for apoptosis induction linked EAF2's tumor-suppressive activity directly to its elongation factor partnership, while Eaf2 knockout mice confirmed multi-organ tumor suppression in vivo.\",\n      \"evidence\": \"Deletion mutagenesis with colony formation and apoptosis assays; Eaf2−/− mice developing lung adenocarcinoma, B-cell lymphoma, hepatocellular carcinoma, and prostatic intraepithelial neoplasia\",\n      \"pmids\": [\"17044034\", \"17873910\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Transcriptomic targets deregulated in knockout tissues were not identified\", \"Whether EAF2 apoptotic function requires catalytic elongation activity or a scaffolding role was not distinguished\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Discovery that EAF2 binds and stabilizes VHL to suppress HIF1α, and independently interacts with p53 to relieve TSP-1 repression, revealed two distinct anti-angiogenic mechanisms operating through EAF2.\",\n      \"evidence\": \"Co-IP and in vitro binding with domain mapping for VHL; pulse-chase stability assay; elevated HIF1α in Eaf2−/− MEFs; Matrigel plug angiogenesis assay; Co-IP of EAF2–p53 with TSP-1 reporter and CD31 IHC in knockout mice\",\n      \"pmids\": [\"19258512\", \"19826414\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether EAF2 stabilizes VHL by blocking ubiquitination or another degradation pathway was not resolved\", \"Whether the p53 and VHL interactions are mutually exclusive or form a ternary complex was not tested\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Demonstrating that EAF2 directly binds the Wnt4 promoter and represses Wnt4 transcription established a conserved auto-regulatory negative feedback loop between Wnt4 and EAF proteins.\",\n      \"evidence\": \"ChIP showing direct Wnt4 promoter occupancy, zebrafish rescue epistasis, mammalian cell reporter assays\",\n      \"pmids\": [\"20161747\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether EAF2 recruits repressive chromatin modifiers to the Wnt4 promoter was not examined\", \"The relative contribution of EAF1 versus EAF2 to Wnt4 repression in mammals was not resolved\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Genetic epistasis between Eaf2 and Vhl heterozygosity showed synergistic angiogenic dysregulation in vivo, confirming that EAF2's stabilization of VHL is physiologically relevant to HIF1α/VEGF pathway restraint.\",\n      \"evidence\": \"Eaf2−/−Vhl+/− compound mutant mice with quantified hepatic vascular lesions, microvessel density, HIF1α, and VEGF immunostaining\",\n      \"pmids\": [\"21638067\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether EAF2 loss alone is sufficient to fully derepress HIF targets in tissues with intact VHL was not clarified\", \"Single lab observation without independent replication\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Multiple studies in 2013 collectively demonstrated that EAF2 inhibits canonical Wnt/β-catenin signaling by binding β-catenin's Armadillo repeats and forming a complex with Tcf and Axin, cooperates with Pten loss to drive prostate cancer, and that reactive stroma precedes epithelial neoplasia in Eaf2 knockout prostates.\",\n      \"evidence\": \"Co-IP of EAF2 with β-catenin/Tcf/Axin, domain mutagenesis, zebrafish epistasis; Eaf2−/−Pten+/− compound mice with elevated pAkt/pMAPK; multi-strain Eaf2 KO histopathology with temporal analysis of stromal versus epithelial changes\",\n      \"pmids\": [\"23364330\", \"23708662\", \"24260246\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether EAF2 disrupts the β-catenin destruction complex or only transcriptional output was not distinguished\", \"The mechanism linking Eaf2 loss to reactive stroma was not identified\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Identification of Pirin as an EAF2-binding protein that destabilizes EAF2 and blocks its growth-inhibitory activity revealed a potential negative regulator of EAF2 function.\",\n      \"evidence\": \"Yeast two-hybrid screen, co-immunoprecipitation, colony formation assay in LNCaP cells\",\n      \"pmids\": [\"24272884\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No reciprocal in vivo validation of the Pirin–EAF2 axis\", \"Mechanism of Pirin-mediated EAF2 destabilization (proteasomal versus other) was not determined\", \"Single lab observation\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Showing that EAF2 binds FOXA1 and promotes its downregulation, thereby modulating AR transcriptional output, proliferation, and migration, connected EAF2 to androgen receptor signaling circuitry in prostate epithelium.\",\n      \"evidence\": \"Co-IP of EAF2–FOXA1, siRNA epistasis in LNCaP cells with AR reporter, BrdU, and migration assays\",\n      \"pmids\": [\"25808853\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether EAF2 targets FOXA1 for degradation or inhibits its transcription was not fully resolved\", \"In vivo validation of the EAF2–FOXA1 axis was not performed\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Demonstrating that EAF2 is selectively upregulated in germinal center B cells and that its loss causes GC hyperplasia, defective apoptosis, elevated antibodies, and spontaneous autoimmunity extended EAF2's tumor-suppressive apoptotic role to immune homeostasis.\",\n      \"evidence\": \"Eaf2 knockout mice with flow cytometry, in vitro and in vivo GC B-cell apoptosis assays, collagen-induced arthritis model, spontaneous autoantibody measurement\",\n      \"pmids\": [\"26935903\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The transcriptional targets of EAF2 in GC B cells were not identified\", \"Whether EAF2-mediated apoptosis in GC B cells acts through the ELL or VHL axis was not resolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The genome-wide transcriptional targets directly regulated by EAF2 through Pol II elongation, the structural basis of the EAF2–ELL complex, and whether EAF2's distinct partner interactions (ELL, VHL, p53, β-catenin, FOXA1) represent mutually exclusive or combinatorial complexes remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No genome-wide identification of direct EAF2 elongation targets\", \"No structural model of EAF2 alone or in complex\", \"Whether distinct EAF2 complexes are cell-type specific or co-exist within the same cell is unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 2, 3, 5, 8]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [7, 10, 14]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 3]},\n      {\"term_id\": \"GO:0005654\", \"supporting_discovery_ids\": [0, 3]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 2, 3, 5, 8]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [2, 8, 10]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [1, 5, 15]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [15]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [4, 11, 13]}\n    ],\n    \"complexes\": [\n      \"ELL–EAF2 elongation complex\",\n      \"β-catenin–Tcf–Axin–EAF2 complex\"\n    ],\n    \"partners\": [\n      \"ELL\",\n      \"VHL\",\n      \"TP53\",\n      \"CTNNB1\",\n      \"FOXA1\",\n      \"PIR\",\n      \"AXIN1\",\n      \"TCF7L2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"EAF2 (ELL-associated factor 2/U19) is a transcriptional elongation cofactor and multi-organ tumor suppressor that links RNA polymerase II regulation with apoptosis, angiogenesis, and immune homeostasis. EAF2 binds ELL through an N-terminal domain (aa 68–113) that is required for nuclear speckle formation, protein stability, and pro-apoptotic activity; ELL co-expression enhances EAF2 transactivation and growth-suppressive function [PMID:12446457, PMID:17044034, PMID:16114057]. Beyond transcription elongation, EAF2 directly stabilizes pVHL to suppress HIF1α-driven angiogenesis, interacts with p53 to relieve repression of the anti-angiogenic factor thrombospondin-1, and inhibits canonical Wnt/β-catenin signaling by binding β-catenin, Tcf, and c-Jun [PMID:19258512, PMID:19826414, PMID:23364330]. EAF2 knockout mice develop multi-organ tumors including lung adenocarcinoma, B-cell lymphoma, and prostatic intraepithelial neoplasia, and EAF2 deficiency in germinal center B cells causes excessive humoral immunity and autoantibody production, establishing EAF2 as a critical regulator of apoptosis in both epithelial and lymphoid compartments [PMID:17873910, PMID:26935903].\",\n  \"teleology\": [\n    {\n      \"year\": 2002,\n      \"claim\": \"Identifying EAF2 as a second ELL-binding partner established the molecular basis of an ELL-associated elongation cofactor family and revealed that EAF2 co-localizes with ELL in nuclear speckles.\",\n      \"evidence\": \"Co-IP across multiple cell lines, confocal microscopy, deletion mapping, and retroviral bone marrow transduction showing MLL-EAF2 fusion immortalizes progenitors\",\n      \"pmids\": [\"12446457\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Endogenous stoichiometry of EAF2–ELL complexes undefined\", \"Whether EAF2 and EAF1 compete or cooperate for ELL binding unresolved\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Demonstrating that EAF2 overexpression induces apoptosis in diverse cell lines and that EAF2 is downregulated with allelic loss in clinical prostate cancers established it as a candidate tumor suppressor downstream of androgen signaling.\",\n      \"evidence\": \"Forced expression in 12 cell lines, in vivo xenograft apoptosis assay, LOH analysis in 23 prostate tumor specimens\",\n      \"pmids\": [\"12907652\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular pathway from EAF2 to apoptosis execution unknown at this stage\", \"Whether androgen regulation of EAF2 is direct or indirect undetermined\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Placing EAF2 downstream of non-canonical Wnt-4 signaling in Xenopus eye development and showing it regulates the eye-field transcription factor Rx linked transcription elongation factor activity to a specific developmental patterning pathway.\",\n      \"evidence\": \"Morpholino knockdown causing eye loss, mRNA rescue of Wnt-4 loss-of-function, neuralized animal cap assays in Xenopus\",\n      \"pmids\": [\"15775981\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct transcriptional targets of EAF2 in eye specification besides Rx not identified\", \"Whether the elongation factor activity is specifically required versus a transcription-activation function unclear\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Showing that ELL binding is required for EAF2 nuclear speckle localization, protein stability, and transactivation revealed a dependency wherein EAF2 function is contingent on ELL complex formation.\",\n      \"evidence\": \"Co-transfection, co-IP, protein stability assay, and transactivation reporter assays\",\n      \"pmids\": [\"16114057\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether other ELL family members (ELL2, ELL3) can substitute is unknown\", \"Mechanism of ELL-mediated stabilization (proteasomal protection versus other) not determined\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Mapping the pro-apoptotic and growth-suppressive activity to the ELL-binding domain (aa 68–113) unified the transcription elongation and tumor suppressor functions into a single structural determinant, while Eaf2-knockout mice confirmed multi-organ tumor suppressor activity in vivo.\",\n      \"evidence\": \"Deletion mutagenesis with colony formation and co-IP readouts; Eaf2-KO mice developing lung adenocarcinoma, B-cell lymphoma, hepatocellular carcinoma, and PIN\",\n      \"pmids\": [\"17044034\", \"17873910\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether apoptosis requires elongation factor activity per se or an independent ELL-mediated function unresolved\", \"Downstream apoptotic effectors not identified\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Discovery that EAF2 directly binds and stabilizes pVHL, thereby suppressing HIF1α levels and angiogenesis, provided a mechanistic link between EAF2 loss and the pro-angiogenic microenvironment observed in tumors; separately, interaction with p53 to block TSP-1 repression revealed an additional anti-angiogenic axis.\",\n      \"evidence\": \"Co-IP, in vitro binding, pulse-chase stability assays, Matrigel plug angiogenesis assay in KO mice (pVHL); Co-IP with p53, TSP-1 promoter luciferase reporter, KO mouse IHC (p53/TSP-1)\",\n      \"pmids\": [\"19258512\", \"19826414\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether EAF2 binding to pVHL occurs in the same complex as ELL is unknown\", \"Structural basis of EAF2–pVHL and EAF2–p53 interactions not resolved\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"ChIP-based demonstration that EAF2 directly binds the Wnt4 promoter to suppress its transcription, while Wnt4 upregulates EAF2, established a conserved auto-regulatory negative feedback loop.\",\n      \"evidence\": \"ChIP in zebrafish embryos and mammalian cells, morpholino/mRNA rescue in zebrafish, reporter assays\",\n      \"pmids\": [\"20161747\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether EAF2 occupancy at the Wnt4 promoter requires ELL unresolved\", \"Full set of EAF2 chromatin targets genome-wide not mapped\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Identification of EAF2 as an inhibitor of canonical Wnt/β-catenin signaling — binding β-catenin's Armadillo repeats, Tcf, c-Jun, and Axin — expanded its role from a non-canonical Wnt effector to a direct antagonist of the canonical Wnt pathway, while genetic epistasis with Pten loss showed synergistic prostate carcinogenesis in vivo.\",\n      \"evidence\": \"Co-IP and domain mapping of β-catenin/Tcf/c-Jun/Axin complexes, β-catenin reporter assays, zebrafish epistasis; Eaf2−/−Pten+/− double-mutant mice developing spontaneous prostate cancer with elevated phospho-Akt\",\n      \"pmids\": [\"23364330\", \"23708662\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether EAF2 disrupts β-catenin–Tcf complex on chromatin or sequesters it in the nucleoplasm is unclear\", \"Full spectrum of pathways synergizing with EAF2 loss beyond Pten and VHL not explored\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Identification of Pirin as a binding partner that destabilizes EAF2 protein and blocks its growth-suppressive function revealed a post-translational regulatory mechanism controlling EAF2 abundance.\",\n      \"evidence\": \"Yeast two-hybrid screen validated by co-IP in mammalian cells, protein stability assays, colony formation assays\",\n      \"pmids\": [\"24272884\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which Pirin destabilizes EAF2 (proteasomal, lysosomal) not determined\", \"Physiological relevance of Pirin–EAF2 interaction in vivo not tested\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Demonstrating that EAF2 binds and destabilizes FOXA1, with FOXA1 required for the enhanced AR-target gene expression seen upon EAF2 loss, placed EAF2 upstream of the FOXA1–AR transcriptional axis in prostate cells.\",\n      \"evidence\": \"Co-IP in prostate cancer cells, double-knockdown epistasis, BrdU proliferation and migration assays, cross-species validation via C. elegans RNAi screen\",\n      \"pmids\": [\"25808853\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether EAF2 regulates FOXA1 at the protein stability or transcriptional level precisely is unresolved\", \"Genome-wide AR-target gene changes upon EAF2 loss not profiled\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Showing that EAF2 promotes apoptosis specifically in germinal center B cells and that its loss leads to excessive antibody production and spontaneous autoimmunity extended EAF2's tumor-suppressive apoptosis function to immune homeostasis.\",\n      \"evidence\": \"Eaf2-KO mice with enlarged GCs, elevated antibodies, collagen-induced arthritis model, spontaneous autoantibody production with aging, flow cytometry and in vitro apoptosis assays\",\n      \"pmids\": [\"26935903\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism by which EAF2 triggers GC B-cell apoptosis not identified\", \"Whether EAF2's ELL-binding domain is required for B-cell apoptosis unknown\", \"Relationship between EAF2-mediated B-cell lymphoma suppression and GC apoptosis not directly tested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Critical open questions include the direct transcriptional target repertoire of EAF2 genome-wide, the structural basis of its interactions with ELL, pVHL, β-catenin, and p53, and the molecular effectors through which EAF2 activates apoptosis in epithelial and germinal center B cells.\",\n      \"evidence\": \"No genome-wide ChIP-seq or structural data reported in the literature\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No genome-wide chromatin occupancy map for EAF2\", \"No crystal or cryo-EM structure of EAF2 or any EAF2 complex\", \"Downstream apoptotic pathway (intrinsic vs extrinsic) not delineated\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 3, 4, 5, 9]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [9]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [7, 8, 11, 15]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 4]},\n      {\"term_id\": \"GO:0005654\", \"supporting_discovery_ids\": [0, 4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0005654\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 3, 4, 5, 9]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [3, 9, 11]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [2, 5, 6, 16]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [16]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [1, 3]}\n    ],\n    \"complexes\": [\n      \"ELL–EAF2 transcription elongation complex\"\n    ],\n    \"partners\": [\n      \"ELL\",\n      \"VHL\",\n      \"TP53\",\n      \"CTNNB1\",\n      \"FOXA1\",\n      \"PIR\",\n      \"TCF7L2\",\n      \"JUN\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}